A detailed history of Cibc World Market Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Cibc World Market Inc. holds 58,983 shares of MRNA stock, worth $2.38 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
58,983
Previous 13,461 338.18%
Holding current value
$2.38 Million
Previous $1.6 Million 146.68%
% of portfolio
0.01%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$63.64 - $125.14 $2.9 Million - $5.7 Million
45,522 Added 338.18%
58,983 $3.94 Million
Q2 2024

Aug 07, 2024

SELL
$101.21 - $166.61 $5.03 Million - $8.27 Million
-49,665 Reduced 78.68%
13,461 $1.6 Million
Q1 2024

May 13, 2024

BUY
$85.37 - $115.44 $2.97 Million - $4.01 Million
34,734 Added 122.34%
63,126 $6.73 Million
Q4 2023

Feb 13, 2024

SELL
$69.51 - $104.43 $2.46 Million - $3.69 Million
-35,335 Reduced 55.45%
28,392 $2.82 Million
Q3 2023

Nov 13, 2023

SELL
$96.41 - $126.61 $2.57 Million - $3.37 Million
-26,608 Reduced 29.45%
63,727 $6.58 Million
Q2 2023

Aug 11, 2023

SELL
$118.5 - $160.53 $3.4 Million - $4.61 Million
-28,713 Reduced 24.12%
90,335 $11 Million
Q1 2023

May 12, 2023

BUY
$135.66 - $197.02 $1.7 Million - $2.47 Million
12,527 Added 11.76%
119,048 $18.3 Million
Q4 2022

Feb 13, 2023

SELL
$118.38 - $210.04 $1.79 Million - $3.18 Million
-15,150 Reduced 12.45%
106,521 $19.1 Million
Q3 2022

Nov 10, 2022

SELL
$118.07 - $194.18 $3.36 Million - $5.52 Million
-28,438 Reduced 18.94%
121,671 $14.4 Million
Q2 2022

Aug 10, 2022

SELL
$117.13 - $176.59 $269,399 - $406,157
-2,300 Reduced 1.51%
150,109 $21.4 Million
Q1 2022

May 12, 2022

BUY
$126.46 - $235.05 $1.9 Million - $3.54 Million
15,055 Added 10.96%
152,409 $26.3 Million
Q4 2021

Feb 14, 2022

SELL
$225.82 - $368.51 $5.05 Million - $8.25 Million
-22,379 Reduced 14.01%
137,354 $34.9 Million
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $9.39 Million - $20.5 Million
42,302 Added 36.02%
159,733 $61.5 Million
Q2 2021

Aug 12, 2021

SELL
$129.91 - $234.98 $19,096 - $34,542
-147 Reduced 0.13%
117,431 $27.6 Million
Q1 2021

May 11, 2021

BUY
$109.18 - $185.98 $10.7 Million - $18.3 Million
98,378 Added 512.39%
117,578 $15.4 Million
Q4 2020

Feb 08, 2021

BUY
$65.74 - $169.86 $907,935 - $2.35 Million
13,811 Added 256.28%
19,200 $2.01 Million
Q3 2020

Nov 12, 2020

SELL
$54.34 - $94.85 $1.34 Million - $2.33 Million
-24,601 Reduced 82.03%
5,389 $381,000
Q2 2020

Aug 13, 2020

BUY
$29.67 - $80.0 $889,803 - $2.4 Million
29,990 New
29,990 $1.93 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Cibc World Market Inc. Portfolio

Follow Cibc World Market Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.